These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 31404503)
1. AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR. Collodet C; Foretz M; Deak M; Bultot L; Metairon S; Viollet B; Lefebvre G; Raymond F; Parisi A; Civiletto G; Gut P; Descombes P; Sakamoto K FASEB J; 2019 Nov; 33(11):12374-12391. PubMed ID: 31404503 [TBL] [Abstract][Full Text] [Related]
2. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Paquette M; El-Houjeiri L; C Zirden L; Puustinen P; Blanchette P; Jeong H; Dejgaard K; Siegel PM; Pause A Autophagy; 2021 Dec; 17(12):3957-3975. PubMed ID: 33734022 [TBL] [Abstract][Full Text] [Related]
3. The Transcription Factors TFEB and TFE3 Link the FLCN-AMPK Signaling Axis to Innate Immune Response and Pathogen Resistance. El-Houjeiri L; Possik E; Vijayaraghavan T; Paquette M; Martina JA; Kazan JM; Ma EH; Jones R; Blanchette P; Puertollano R; Pause A Cell Rep; 2019 Mar; 26(13):3613-3628.e6. PubMed ID: 30917316 [TBL] [Abstract][Full Text] [Related]
4. Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis. El-Houjeiri L; Biondini M; Paquette M; Kuasne H; Pacis A; Park M; Siegel PM; Pause A J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779410 [TBL] [Abstract][Full Text] [Related]
5. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174 [TBL] [Abstract][Full Text] [Related]
6. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways. Ramirez Reyes JMJ; Cuesta R; Pause A Front Cell Dev Biol; 2021; 9():667311. PubMed ID: 33981707 [No Abstract] [Full Text] [Related]
7. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue. Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603 [TBL] [Abstract][Full Text] [Related]
8. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases. Petit CS; Roczniak-Ferguson A; Ferguson SM J Cell Biol; 2013 Sep; 202(7):1107-22. PubMed ID: 24081491 [TBL] [Abstract][Full Text] [Related]
11. The anti-tumor agent, Dp44mT, promotes nuclear translocation of TFEB via inhibition of the AMPK-mTORC1 axis. Krishan S; Sahni S; Richardson DR Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165970. PubMed ID: 32950675 [TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation. Yan M; Gingras MC; Dunlop EA; Nouët Y; Dupuy F; Jalali Z; Possik E; Coull BJ; Kharitidi D; Dydensborg AB; Faubert B; Kamps M; Sabourin S; Preston RS; Davies DM; Roughead T; Chotard L; van Steensel MA; Jones R; Tee AR; Pause A J Clin Invest; 2014 Jun; 124(6):2640-50. PubMed ID: 24762438 [TBL] [Abstract][Full Text] [Related]
13. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome. Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100 [TBL] [Abstract][Full Text] [Related]
14. Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway. Piao X; Kobayashi T; Wang L; Shiono M; Takagi Y; Sun G; Abe M; Hagiwara Y; Zhang D; Okimoto K; Kouchi M; Matsumoto I; Hino O Biochem Biophys Res Commun; 2009 Nov; 389(1):16-21. PubMed ID: 19695222 [TBL] [Abstract][Full Text] [Related]
15. Loss of FLCN inhibits canonical WNT signaling via TFE3. Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105 [TBL] [Abstract][Full Text] [Related]
16. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome. Napolitano G; Di Malta C; Esposito A; de Araujo MEG; Pece S; Bertalot G; Matarese M; Benedetti V; Zampelli A; Stasyk T; Siciliano D; Venuta A; Cesana M; Vilardo C; Nusco E; Monfregola J; Calcagnì A; Di Fiore PP; Huber LA; Ballabio A Nature; 2020 Sep; 585(7826):597-602. PubMed ID: 32612235 [TBL] [Abstract][Full Text] [Related]
17. Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. Hudon V; Sabourin S; Dydensborg AB; Kottis V; Ghazi A; Paquet M; Crosby K; Pomerleau V; Uetani N; Pause A J Med Genet; 2010 Mar; 47(3):182-9. PubMed ID: 19843504 [TBL] [Abstract][Full Text] [Related]
18. Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia. Zhong M; Zhao X; Li J; Yuan W; Yan G; Tong M; Guo S; Zhu Y; Jiang Y; Liu Y; Jiang Y J Biol Chem; 2016 May; 291(22):11689-97. PubMed ID: 27072130 [TBL] [Abstract][Full Text] [Related]
19. Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation. Hasumi Y; Baba M; Hasumi H; Huang Y; Lang M; Reindorf R; Oh HB; Sciarretta S; Nagashima K; Haines DC; Schneider MD; Adelstein RS; Schmidt LS; Sadoshima J; Marston Linehan W Hum Mol Genet; 2014 Nov; 23(21):5706-19. PubMed ID: 24908670 [TBL] [Abstract][Full Text] [Related]
20. Transcription factor EB and TFE3: new metabolic coordinators mediating adaptive responses to exercise in skeletal muscle? Markby GR; Sakamoto K Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E763-E768. PubMed ID: 32830550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]